Literature DB >> 32478724

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing.

Hedwig M Braakhuis1, Ruiwen He2, Rob J Vandebriel3, Eric R Gremmer3, Edwin Zwart3, Jolanda P Vermeulen3, Paul Fokkens3, John Boere3, Ilse Gosens3, Flemming R Cassee2.   

Abstract

For toxicity testing of airborne particles, air-liquid interface (ALI) exposure systems have been developed for in vitro tests in order to mimic realistic exposure conditions. This puts specific demands on the cell culture models. Many cell types are negatively affected by exposure to air (e.g., drying out) and only remain viable for a few days. This limits the exposure conditions that can be used in these models: usually relatively high concentrations are applied as a cloud (i.e., droplets containing particles, which settle down rapidly) within a short period of time. Such experimental conditions do not reflect realistic long-term exposure to low concentrations of particles. To overcome these limitations the use of a human bronchial epithelial cell line, Calu-3 was investigated. These cells can be cultured at ALI conditions for several weeks while retaining a healthy morphology and a stable monolayer with tight junctions. In addition, this bronchial model is suitable for testing the effects of repeated exposures to low, realistic concentrations of airborne particles using an ALI exposure system. This system uses a continuous airflow in contrast to other ALI exposure systems that use a single nebulization producing a cloud. Therefore, the continuous flow system is suitable for repeated and prolonged exposure to airborne particles while continuously monitoring the particle characteristics, exposure concentration, and delivered dose. Taken together, this bronchial model, in combination with the continuous flow exposure system, is able to mimic realistic, repeated inhalation exposure conditions that can be used for toxicity testing.

Entities:  

Year:  2020        PMID: 32478724     DOI: 10.3791/61210

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  7 in total

1.  Methods, models, mechanisms and metadata: Introducing the Nanotoxicology collection at F1000Research.

Authors:  Iseult Lynch; Penny Nymark; Philip Doganis; Mary Gulumian; Tae-Hyun Yoon; Diego S T Martinez; Antreas Afantitis
Journal:  F1000Res       Date:  2021-11-24

2.  Automation and Standardization-A Coupled Approach towards Reproducible Sample Preparation Protocols for Nanomaterial Analysis.

Authors:  Jörg Radnik; Vasile-Dan Hodoroaba; Harald Jungnickel; Jutta Tentschert; Andreas Luch; Vanessa Sogne; Florian Meier; Loïc Burr; David Schmid; Christoph Schlager; Tae Hyun Yoon; Ruud Peters; Sophie M Briffa; Eugenia Valsami-Jones
Journal:  Molecules       Date:  2022-02-01       Impact factor: 4.411

3.  Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes.

Authors:  Domizia Baldassi; Shubhankar Ambike; Martin Feuerherd; Cho-Chin Cheng; David J Peeler; Daniel P Feldmann; Diana Leidy Porras-Gonzalez; Xin Wei; Lea-Adriana Keller; Nikolaus Kneidinger; Mircea Gabriel Stoleriu; Andreas Popp; Gerald Burgstaller; Suzie H Pun; Thomas Michler; Olivia M Merkel
Journal:  J Control Release       Date:  2022-03-29       Impact factor: 11.467

4.  A Barrier to Defend - Models of Pulmonary Barrier to Study Acute Inflammatory Diseases.

Authors:  Anna Herminghaus; Andrey V Kozlov; Andrea Szabó; Zoltán Hantos; Severin Gylstorff; Anne Kuebart; Mahyar Aghapour; Bianka Wissuwa; Thorsten Walles; Heike Walles; Sina M Coldewey; Borna Relja
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

5.  Carbon nanoparticles adversely affect CFTR expression and toxicologically relevant pathways.

Authors:  Torben Stermann; Thach Nguyen; Burkhard Stahlmecke; Ana Maria Todea; Selina Woeste; Inken Hacheney; Jean Krutmann; Klaus Unfried; Roel P F Schins; Andrea Rossi
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

6.  In Vitro Toxicity of Industrially Relevant Engineered Nanoparticles in Human Alveolar Epithelial Cells: Air-Liquid Interface versus Submerged Cultures.

Authors:  Maria João Bessa; Fátima Brandão; Paul H B Fokkens; Daan L A C Leseman; A John F Boere; Flemming R Cassee; Apostolos Salmatonidis; Mar Viana; Adriana Vulpoi; Simion Simon; Eliseo Monfort; João Paulo Teixeira; Sónia Fraga
Journal:  Nanomaterials (Basel)       Date:  2021-11-27       Impact factor: 5.076

7.  Human models for COVID-19 research.

Authors:  Maximillian N J Woodall; Tereza Masonou; Katie-Marie Case; Claire M Smith
Journal:  J Physiol       Date:  2021-08-17       Impact factor: 6.228

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.